Maternal Gut Microbiome as a Predictor of Insulin Therapy Requirement in Gestational Diabetes

Our findings demonstrate that integrating gut microbiome characteristics with clinical data improves the prediction of insulin treatment needs in GDM, particularly for BI initiation.